Grazoprevir hydrate T21456
Specifications
| 1mg/5mg/10mg/25mg/50mg/100mg |
Bioactivity:
Grazoprevir, a second generation hepatitis C virus protease inhibitor acting at the NS3/4a protease targets, has good activity against a range of hepatitis C virus genotype variants, including some that are resistant to most currently used antiviral medic
CAS nr:
1350462-55-3
Purity:
98%
Molecular Weight:
784,93
SMILES:
O=C([C@H]1N(C2)C([C@H](C(C)(C)C)NC(O[C@@]3([H])[C@](C3)([H])CCCCCC4=NC5=CC=C(OC)C=C5N=C4O[C@]2([H])C1)=O)=O)N[C@@]6(C(NS(=O)(C7CC7)=O)=O)[C@H](C=C)C6.[H]O[H]
Formula:
C38H52N6O10S
Pathway:
Target:
